ICICI Prudential Life

Size: px
Start display at page:

Download "ICICI Prudential Life"

Transcription

1 INDUSTRY INSURANCE CMP (as on 24 Apr 2018) Rs 418 Target Price Rs 515 Nifty 10,614 Sensex 34,617 KEY STOCK DATA Bloomberg IPRU IN No. of Shares (mn) 1,435 MCap (Rs bn) / ($ mn) 600/9,054 6m avg traded value (Rs mn) 536 STOCK PERFORMANCE (%) 52 Week high / low Rs 507/363 3M 6M 12M Absolute (%) (3.8) Relative (%) (12.3) SHAREHOLDING PATTERN (%) Promoters 80.7 FIs & Local MFs 3.8 FPIs 6.5 Public & Others 9.0 Source : BSE Madhukar Ladha madhukar.ladha@hdfcsec.com Stellar Margins ICICI Pru Life delivered a strong set of numbers of 4Q. Higher share of protection, operating efficiency and lower tax rate drove its full year margin to 16.5% (9M: 13.7%). With this margin, ICICI Pru has narrowed margin gap with competitors despite higher share of ULIPs (VNB Margins- HDFC Life: 23.2%; SBI Life: 16%, Max Life: 18.5%). 4Q APE came in at Rs.22.1bn (+2.1% YoY); growth was subdued on higher base and as new business premium declined in Jan and Feb 18. For, IPRU recorded New Business and Renewal Business premiums of Rs96.2bn (+17.1%) and Rs77.9bn (+23.1% YoY) respectively. For, savings and protection APE grew 71.5% and 15.4% respectively resulting in the share of protection improving 180bps to 5.7%. Strong improvement in margin resulted in VNB increasing 93.1% in to Rs 12.9bn. PAT for the quarter was down 16.4% YoY at Rs 3.4bn due to high new business strain and negative investment income. We upgrade our margin assumptions resulting in VNB increasing by 19.9/19.7% RESULTS REVIEW 4Q 25 APR 2018 ICICI Prudential Life BUY for FY19/20. We continue to like ICICI Pru Life as it benefits from financialization of savings and further margin levers. We maintain BUY with an increased TP of Rs 515 (FY20 EV+ 25x FY20E VNB). Highlights of the quarter Management highlighted increase in margin for doesn t have any one offs (while change in tax rate does provide a bump up to margins it is recurring in nature) and expects further improvements in margins as share of protection increases and persistency sustains in all the buckets. For contribution of ULIP is 81.9% compared to 84.1% in. 13 th persistency (without single premium) improved to 86.9% in 11M from 84.7% (). ROEV for stood at 23.4% compared to 16.5% in as lower tax rate boosted operating variance. AUM increased 0.8% QoQ to Rs 1.4tn with 47% Equity mix. Near-term outlook: We expect premium growth to improve. Business Summary (Rs bn) 4Q 4Q YoY (%) 3Q QoQ (%) E FY19E FY20E NBP APE VNB NM NM NM NM NM VNB Margin (%) 16.5# 10.3# 640bps 13.7# NM EV MCap/EV (x) P/Bv (x) ROEV # Refers to and margins respectively HDFC securities Institutional Research is also available on Bloomberg HSLB <GO>& Thomson Reuters

2 Protection APE showed stellar growth of ~71% in VNB Margin improved from 10.1% for to 16.5% for. This improvement was largely as a result of change in product mix (higher protection business and more profitable savings products). Company has not yet changed its persistency assumptions despite seeing improvements in the same. It is waiting for sustained improvements in all cohorts. Concall highlights Business ICICI Pru Life continues to focus on customer centric products. While business growth for the quarter (APE +2.1% YoY) looks muted due to high base, over the last 1/3/5yrs, the company has delivered APE growth of 17.6/18.0/17.1%. Renewal premium at Rs175bn was up +23.1% for. Protection has grown strongly at 71% for ; credit life, within protection, has grown the fastest. Protection has contributed 40% to retail business policies issued. 13th persistency, one of the most important parameter for quality of business, has continued to improve and come in at 87.8%; Persistency excluding single premium has also improved for all cohorts. IPRU is using technology to drive superior customer experience cost efficiencies; Currently 64% of policies are issued within 2 days. Company currently has 252% solvency while the regulatory requirement is 150%. As the company grows its capital consuming protection business it may stop paying special dividend in order to conserve capital. Embedded Value and VNB VNB margin has shown strong improvement from 10.1% in to 16.5% in. A 400bps improvement in VNB is attributed to change in product mix i.e. higher protection mix, along with better product features. Product mix and changed features have resulted in better margins. For 9M, the company had reported VNB margin of 13.7%. Other components in VNB margin improvement have been positive expense experience +1.1% and other assumption changes (excluding expenses) of 1.3%. Savings margin is improving also as a result of improving cost efficiencies in assumptions; Company is now using effective tax rate instead of chargeable tax rate. Similar change in VNB resulted in 130bps (most of it) YoY margin improvement. Non-commission based cost has reduced resulting in lower sensitivity of acquisition cost factor to VNB; Improved profitability has also helped sensitivity. ICICI Pru Life has not made any material change in the persistency assumption and continues to remain conservative on this front. It wants to change assumption in a material way only after all cohorts show sustained improvement. A Rs 7.64 bn positive variance in the operating assumption is largely owing to tax related change and is non recurring. Future margin levers: Higher share of Protection, improvement in persistency and cost efficiency would drive further improvement in margins and will also increase EV. Business Outlook Protection business is expected to grow faster than rest of the portfolio. This can further enhance VNB margins. The company is not targeting any specific product mix. Page 2

3 Five Quarters At A Glance (Rs Bn) 4Q 1Q 2Q 3Q 4Q YoY(%) QoQ(%) Growth Growth Premium Earned Premium on re-insurance Net premium earned Investment income Other income Total Income Commission Paid Expenses Tax on policyholder funds claim/benefits paid change in actuarial liability Total outgo PBT Tax on PAT New Business Premium Total APE Savings APE Protection APE Savings APE Share (%) bps -582bps Protection APE Share (%) bps 582bps Cost to Total Premium (%) bps 121bps VNB Margin (%)# bps NA Strong growth in protection business as seen in the changing mix. Partly also as a result of re-classification. Sharp increase in margins driven by product mix, persistency and lower tax rate assumption. AUM Rs (bn) Equity Mix (%) bps -100bps Debt Mix (%) bps +100bps Linked (%) NA NA NA Non-Linked (%) NA NA NA #Refers to 9M and 9M margin; for 4Q is refers to margin Page 3

4 93% jump in YoY NBV in. (Rs Mn) FY16 E Opening IEV 138, , ,840 Value of New Business 4,123 6,660 12,860 Expected return on existing business 17,072 16,290 23,940 IEV operating earnings 21,195 22,950 36,800 Economic variances From actual return in excess of expected real-world return -6,159 5,820 1,120 From change in economic assumption 524 na Na Other non-operating variances Total IEV earnings 15,560 28,770 37,920 Capital contributions / dividend payouts -14,414-6,320-11,880 Closing adjustments Closing IEV-Year End 139, , ,880 ROEV return % 11.3% 20.6% 23.4% APE 51,085 64,965 77,920 VNB Margin 8.1% 10.3% 16.5% ICICI Pru Life % chg in VNB % chg in EV % chg in VNB % chg in EV Reference rate up 100 bps Reference rate down 100 bps Lapse/Surrender rate up 10 % Lapse/Surrender rate down 10 % Maintenance expenses up 10 % Maintenance expenses down 10 % Mortality up 10 % Mortality down 10 % Tax Rate increased to 25%/28.84%* -22% -11% Tax Rate increased to 34.6% NA NA Page 4

5 APE growth was muted at 2.1% YoY. Protection business share improving is hugely beneficial for the company s margins. APE trend ( Rs bn.) Rs bn Total APE FY16 1Q 2Q Growth - RHS 3Q 4Q Product Mix On APE -ULIP -PAR -Non-PAR -Group Protection 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% FY16 Margin has seen a strong improvement on change in tax assumption, higher share of protection business and lower cost assumptions. VNB Trend( Rs bn.) Rs bn VNB VNB Margin - RHS 18.0% 16.0% 14.0% 12.0% 10.0% 8.0% 6.0% 4.0% 2.0% AUM Mix 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% Equity Debt 0.00 FY16 0.0% FY16 1Q 2Q 3Q Page 5

6 Persistency Trend Channel Mix On APE Persistency has been improving across all buckets except for 61 st 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% 13th FY15 FY16 25th 37th 49th 61st Bancassurance Agency Direct Corporate Agents Group 100% 80% 60% 40% 20% 0% FY16 1Q 2Q 3Q 4Q We have changed our margin assumptions resulting in significant increase in our VNB and EV projections. Change In Estimates Rs bn FY19E FY20E New Old Change(%) New Old Change(%) APE 90,609 90,609 0% 108, ,609 0% VNB 15,860 13, % 19,826 16, % VNB Margin (%) 17.5% 14.6% 290bps 18.3% 15.3% 300bps Embedded Value 211, ,813 7% 241, , % Source: HDFC sec Inst Research Peer Comparison Rs Bn Mcap (Rs bn) CMP (Rs) Reco TP VNB EV P/EV (x) VNB Multiple (x) APE GROWTH (%) VNB Margin (%) E FY19E FY20E E FY19E FY20E E FY19E FY20E E FY19E FY20E E FY19E FY20E E FY19E FY20E HDFC Life# 1, NR NR SBI Life BUY % 25.6% 23.7% ICICI Pru Life BUY % 21.8% 19.9% Max Financial BUY % 19.4% 19.4% Source: Companies, HDFC Sec Inst Research, * For Max Life, #Consensus Estimates for HDFC Life Page 6

7 Policyholder AC (Rs mn) FY19E FY20E Total Premium earned 221, , , ,643 Income from investments and other income 150, , , ,163 Transfer from shareholders AC Total Income 371, , , ,805 Commission 7,589 8,950 10,523 12,441 Operating expenses 23,572 27,717 32,116 37,554 Provisions 4,288 4,501 4,725 4,960 Total Expenses 35,450 41,168 47,365 54,955 Benefits Paid 149, , , ,521 Change in valuation of liabilities 174, , , ,498 Total 324, , , ,019 Surplus 11,527 13,628 16,639 17,831 Tax ,159 Net Surplus 10,738 12,696 15,641 16,672 Transfer to shareholders AC 11,315 11,680 14,077 14,505 Shareholders AC (Rs mn) E FY19E FY20E Transfer from policyholders' a/c 11,315 11,680 14,077 14,505 Investment income 6,932 6,641 7,552 8,560 Total income 18,248 18,321 21,629 23,065 Expenses Contribution to policyholders' a/c Profit before tax 17,850 17,913 21,190 22,593 Taxes 1,028 1,164 1,377 1,469 PAT 16,822 16,749 19,813 21,125 Page 7

8 Key Ratios In % E FY19E FY20E Premium Growth NBP Growth 16.2% 22.4% 8.5% 18.8% APE Growth 27.2% 19.8% 16.3% 19.9% Commissions Growth Opex Growth Commissions / premium Opex / premium PAT Growth RoAA RoE EPS (Rs) BV (Rs) DPS (Rs) EV (Rs mn) 161, , , ,122 VNB (Rs mn) 6,660 12,860 15,860 19,826 EVOP (Rs mn) 22,950 36,800 33,854 39,858 ROEV P/E (x) P/ABV (x) P/EV (x) P/NBV (x) Balance Sheet (Rs mn) E FY19E FY20E Source Share capital 14,353 14,353 14,353 14,353 Reserve and surplus 46,996 55,370 65,277 75,839 Net worth 61,350 69,724 79,630 90,193 Credit/debit balance in fair value a/c 2,731 2,731 2,731 2,731 Policyholders' a/c 1,148,941 1,303,167 1,503,855 1,745,352 Funds for future appropriation 6,042 6,785 6,954 7,128 Total Liabilities 1,219,063 1,382,406 1,593,170 1,845,404 Application Shareholders' Investments 66,403 75,520 85,596 96,332 Policyholders' investments 270, Asset to cover linked liabilities 878,783 1,303,683 1,504,371 1,745,869 Loans Fixed assets + DTA 2,138 2,138 2,138 2,138 Net current assets Debit balance in P&L Total Assets 1,219,063 1,382,406 1,593,170 1,845,404 Page 8

9 RECOMMENDATION HISTORY ICICI Pru Life TP Date CMP Reco Target 28-Dec BUY Jan BUY Apr BUY Apr BUY Apr-17 May-17 Jun-17 Jul-17 Aug-17 Sep-17 Oct-17 Nov-17 Dec-17 Jan-18 Feb-18 Mar-18 Apr-18 Rating Definitions BUY : Where the stock is expected to deliver more than 10% returns over the next 12 period NEUTRAL : Where the stock is expected to deliver (-)10% to 10% returns over the next 12 period SELL : Where the stock is expected to deliver less than (-)10% returns over the next 12 period Page 9

10 Disclosure: I, Madhukar Ladha, CA, author and the name subscribed to this report, hereby certify that all of the views expressed in this research report accurately reflect our views about the subject issuer(s) or securities. HSL has no material adverse disciplinary history as on the date of publication of this report. We also certify that no part of our compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report. Research Analyst or his/her relative or HDFC Securities Ltd. does not have any financial interest in the subject company. Also Research Analyst or his relative or HDFC Securities Ltd. or its Associate may have beneficial ownership of 1% or more in the subject company at the end of the immediately preceding the date of publication of the Research Report. Further Research Analyst or his relative or HDFC Securities Ltd. or its associate does not have any material conflict of interest. Any holding in stock No HDFC Securities Limited (HSL) is a SEBI Registered Research Analyst having registration no. INH Disclaimer: This report has been prepared by HDFC Securities Ltd and is meant for sole use by the recipient and not for circulation. The information and opinions contained herein have been compiled or arrived at, based upon information obtained in good faith from sources believed to be reliable. Such information has not been independently verified and no guaranty, representation of warranty, express or implied, is made as to its accuracy, completeness or correctness. All such information and opinions are subject to change without notice. This document is for information purposes only. Descriptions of any company or companies or their securities mentioned herein are not intended to be complete and this document is not, and should not be construed as an offer or solicitation of an offer, to buy or sell any securities or other financial instruments. This report is not directed to, or intended for display, downloading, printing, reproducing or for distribution to or use by, any person or entity who is a citizen or resident or located in any locality, state, country or other jurisdiction where such distribution, publication, reproduction, availability or use would be contrary to law or regulation or what would subject HSL or its affiliates to any registration or licensing requirement within such jurisdiction. If this report is inadvertently send or has reached any individual in such country, especially, USA, the same may be ignored and brought to the attention of the sender. This document may not be reproduced, distributed or published for any purposes without prior written approval of HSL. Foreign currencies denominated securities, wherever mentioned, are subject to exchange rate fluctuations, which could have an adverse effect on their value or price, or the income derived from them. In addition, investors in securities such as ADRs, the values of which are influenced by foreign currencies effectively assume currency risk. It should not be considered to be taken as an offer to sell or a solicitation to buy any security. HSL may from time to time solicit from, or perform broking, or other services for, any company mentioned in this mail and/or its attachments. HSL and its affiliated company(ies), their directors and employees may; (a) from time to time, have a long or short position in, and buy or sell the securities of the company(ies) mentioned herein or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the company(ies) discussed herein or act as an advisor or lender/borrower to such company(ies) or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions. HSL, its directors, analysts or employees do not take any responsibility, financial or otherwise, of the losses or the damages sustained due to the investments made or any action taken on basis of this report, including but not restricted to, fluctuation in the prices of shares and bonds, changes in the currency rates, diminution in the NAVs, reduction in the dividend or income, etc. HSL and other group companies, its directors, associates, employees may have various positions in any of the stocks, securities and financial instruments dealt in the report, or may make sell or purchase or other deals in these securities from time to time or may deal in other securities of the companies / organizations described in this report. HSL or its associates might have managed or co-managed public offering of securities for the subject company or might have been mandated by the subject company for any other assignment in the past twelve s. HSL or its associates might have received any compensation from the companies mentioned in the report during the period preceding twelve s from t date of this report for services in respect of managing or co-managing public offerings, corporate finance, investment banking or merchant banking, brokerage services or other advisory service in a merger or specific transaction in the normal course of business. HSL or its analysts did not receive any compensation or other benefits from the companies mentioned in the report or third party in connection with preparation of the research report. Accordingly, neither HSL nor Research Analysts have any material conflict of interest at the time of publication of this report. Compensation of our Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions. HSL may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report. Research entity has not been engaged in market making activity for the subject company. Research analyst has not served as an officer, director or employee of the subject company. We have not received any compensation/benefits from the subject company or third party in connection with the Research Report. HDFC securities Limited, I Think Techno Campus, Building - B, "Alpha", Office Floor 8, Near Kanjurmarg Station, Opp. Crompton Greaves, Kanjurmarg (East), Mumbai Phone: (022) Fax: (022) Compliance Officer: Binkle R. Oza complianceofficer@hdfcsec.com Phone: (022) HDFC Securities Limited, SEBI Reg. No.: NSE-INB/F/E , BSE-INB/F , AMFI Reg. No. ARN: 13549, PFRDA Reg. No. POP: , IRDA Corporate Agent License No.: HDF /HDF C , SEBI Research Analyst Reg. No.: INH , CIN - U67120MH2000PLC Mutual Funds Investments are subject to market risk. Please read the offer and scheme related documents carefully before investing. Page 10

11 HDFC securities Institutional Equities Unit No. 1602, 16th Floor, Tower A, Peninsula Business Park, Senapati Bapat Marg, Lower Parel, Mumbai Board : Page 11

Max Financial. Improving margins! BUY RESULTS REVIEW 4QFY18 30 MAY Highlights of the quarter

Max Financial. Improving margins! BUY RESULTS REVIEW 4QFY18 30 MAY Highlights of the quarter INDUSTRY Life Insurance CMP (as on 30 May 2018) Rs 485 Target Price Rs 665 Nifty 10,614 Sensex 34,906 KEY STOCK DATA Bloomberg MAXF IN No. of Shares (mn) 268 MCap (Rs bn) / ($ mn) 130/1,924 6m avg traded

More information

Healty cigarette-driven growth

Healty cigarette-driven growth INDUSTRY FMCG CMP (as on 27 Jul 2017) Rs 289 Target Price Rs 353 Nifty 10,021 Sensex 32,383 KEY STOCK DATA Bloomberg ITC IN No. of Shares (mn) 12,161 12,162 MCap (Rs bn)/(us$ mn) 3,509/54,743 6m avg traded

More information

Jubilant FoodWorks NEUTRAL RESULTS REVIEW 4QFY17 30 MAY Highlights of the quarter

Jubilant FoodWorks NEUTRAL RESULTS REVIEW 4QFY17 30 MAY Highlights of the quarter INDUSTRY FMCG CMP (as on 29 May 17) Rs 94 Target Price Rs 995 Nifty 9,65 Sensex 31,19 KEY STOCK DATA Bloomberg JUBI IN No. of Shares (mn) 66 MCap (Rs bn)/(us$ mn) 62/962 6m avg traded value (Rs mn) 574

More information

Jubilant FoodWorks BUY RESULTS REVIEW 1QFY18 18 JULY Highlights of the quarter

Jubilant FoodWorks BUY RESULTS REVIEW 1QFY18 18 JULY Highlights of the quarter INDUSTRY FMCG CMP (as on 17 Jul 17) Rs 1,273 Target Price Rs 1,45 Nifty 9,916 Sensex 32,75 KEY STOCK DATA Bloomberg JUBI IN No. of Shares (mn) 66 MCap (Rs bn)/(us$ mn) 84/1,35 6m avg traded value (Rs mn)

More information

BLS International Services

BLS International Services INDUSTRY IT Processing CMP (as on 23 May 218) Rs 17 TP Rs 23 Nifty 1,43 Sensex 34,345 KEY STOCK DATA Bloomberg BLSIN IN No. of Shares (mn) 12 MCap (Rs bn) / ($ mn) 18/255 6m avg traded value (Rs mn) 89

More information

Agrochemicals. 3QFY18E Results Preview 09 JAN Basanth Patil

Agrochemicals. 3QFY18E Results Preview 09 JAN Basanth Patil Agrochemicals FY18E Results Preview 09 JAN 2018 Basanth Patil basanth.patil@hdfcsec.com +91-22-6171-7319 FY18E: Highest rabi sowing; stable results expected Agrochemicals: A normal monsoon in 2017 and

More information

Crompton Greaves Consumer Electricals

Crompton Greaves Consumer Electricals INDUSTRY APPLIANCES CMP (as on 27 Oct 2017) Rs 219 Target Price Rs 268 Nifty 10,323 Sensex 33,157 KEY STOCK DATA Bloomberg CROMPTON IN No. of Shares (mn) 627 MCap (Rs bn)/(us$ mn) 137/2,106 6m avg traded

More information

Crompton Greaves Consumer Electricals

Crompton Greaves Consumer Electricals INDUSTRY APPLIANCES CMP (as on 27 July 2017) Rs 209 Target Price Rs 252 Nifty 10,021 Sensex 32,383 KEY STOCK DATA Bloomberg CROMPTON IN No. of Shares (mn) 627 MCap (Rs bn)/(us$ mn) 131/2,046 6m avg traded

More information

Agriculture. 4QFY18E Results Preview 13 APR Madhukar Ladha

Agriculture. 4QFY18E Results Preview 13 APR Madhukar Ladha Agriculture FY18E Results Preview 13 APR 2018 Basanth Patil basanth.patil@hdfcsec.com +91-22-6171-7319 Madhukar Ladha madhukar.ladha@hdfcsec.com +91-22-6171-7323 Agrochemicals: Stable results expected

More information

Multi Commodity Exchange

Multi Commodity Exchange INDUSTRY EXCHANGES CMP (as on 30 Apr 2018) Rs 779 Target Price Rs 1,040 Nifty 10,739 Sensex 35,160 KEY STOCK DATA Bloomberg MCX IN No. of Shares (mn) 51 MCap (Rs bn) / ($ mn) 40/595 6m avg traded value

More information

Gulf Oil Lubricants BUY RESULTS REVIEW 1QFY19 09 AUG Key highlights

Gulf Oil Lubricants BUY RESULTS REVIEW 1QFY19 09 AUG Key highlights INDUSTRY LUBRICANT CMP (as on 8 Aug 2018) Rs 872 Target Price Rs 1,027 Nifty 11,450 Sensex 37,888 KEY STOCK DATA Bloomberg GOLI IN No. of Shares (mn) 50 MCap (Rs bn)/(us$ mn) 43/633 6m avg traded value

More information

Capital Goods. 3QFY18E Results Preview. 10 Jan Sujit Jain

Capital Goods. 3QFY18E Results Preview. 10 Jan Sujit Jain Capital Goods Results Preview 10 Jan 2018 Sujit Jain sujit.jain@hdfcsec.com +91-22-6171 7314 Basanth Patil basanth.patil@hdfcsec.com +91-22-6171 7319 FY16 4Q FY16 1Q FY17 2Q FY17 FY17 4Q FY17 1Q FY18 2Q

More information

Real Estate. 3QFY19E Results Preview. 11 Jan Parikshit D Kandpal, CFA

Real Estate. 3QFY19E Results Preview. 11 Jan Parikshit D Kandpal, CFA Real Estate Results Preview 11 Jan 2019 Parikshit D Kandpal, CFA parikshit.kandpal@hdfcsec.com +91-22-6171 7317 Kunal Bhandari kunal.bhandari@hdfcsec.com +91-22-6639 3035 FY14 4QFY14 1QFY15 2QFY15 FY15

More information

Intellect Design Arena

Intellect Design Arena INDUSTRY IT PRODUCTS CMP (as on 07 May 2018) Rs 209 Target Price Rs 275 Nifty 10,716 Sensex 35,208 KEY STOCK DATA Bloomberg INDA IN No. of Shares (mn) 126 MCap (Rs bn) / ($ mn) 26/391 6m avg traded value

More information

Navin Fluorine International

Navin Fluorine International RESULTS REVIEW 1QFY19 26 JUL 2018 Navin Fluorine International INDUSTRY CHEMICALS CMP (as on 26 Jul 2018) Rs 649 Target Price Rs 915 Nifty 11,167 Sensex 36,985 KEY STOCK DATA Bloomberg NFIL IN No. of Shares

More information

Near-term pressure, but long-term outlook positive

Near-term pressure, but long-term outlook positive INDUSTRY IT CMP (as on 2 Nov 2015) Rs 1,812 Target Price Rs 2,050 Nifty 8,051 Sensex 26,559 KEY STOCK DATA Bloomberg ECLX IN No. of Shares (mn) 30 MCap (Rs bn) / ($ mn) 55/843 6m avg traded value (Rs mn)

More information

SBI Life Insurance Company

SBI Life Insurance Company Industry Life Insurance CMP Rs. 689.25 Recommendation Buy at CMP and Add on Dips Add on dips to Rs. 689-642 Target Rs. 840 Time Horizon 4 Quarters HDFC Scrip Code SBILIF BSE Code 540719 NSE Code Bloomberg

More information

Neuland Labs BUY RESULTS REVIEW 1QFY19 12 AUG 2018

Neuland Labs BUY RESULTS REVIEW 1QFY19 12 AUG 2018 RESULTS REVIEW 1QFY19 12 AUG 2018 Neuland Labs INDUSTRY PHARMA CMP (as on 10 Aug 2018) Rs 687 Target Price Rs 914 Nifty 11,430 Sensex 37,869 KEY STOCK DATA Bloomberg NLL IN No. of Shares (mn) 17 MCap (Rs

More information

Max Financial BUY RESULTS REVIEW 1QFY19 07 AUG Highlights of the quarter

Max Financial BUY RESULTS REVIEW 1QFY19 07 AUG Highlights of the quarter INDUSTRY Life Insurance CMP (as on 07 Aug 2018) Rs 491 Target Price Rs 577 Nifty 11,389 Sensex 37,666 KEY STOCK DATA Bloomberg MAXF IN No. of Shares (mn) 268 MCap (Rs bn) / ($ mn) 132/1,918 6m avg traded

More information

J. Kumar Infraprojects

J. Kumar Infraprojects RESULTS REVIEW 4QFY17 30 MAY 2017 J. Kumar Infraprojects BUY INDUSTRY INFRASTRUCTURE CMP (as on 30 May 2017) Rs 299 Target Price Rs 351 Nifty 9,625 Sensex 31,159 KEY STOCK DATA Bloomberg JKIL IN No. of

More information

BHEL SELL RESULTS REVIEW 1QFY15 13 AUG CMP (as on 12 Aug 2014) Rs 224 Target Price Rs 188

BHEL SELL RESULTS REVIEW 1QFY15 13 AUG CMP (as on 12 Aug 2014) Rs 224 Target Price Rs 188 RESULTS REVIEW 1QFY15 13 AUG 2014 BHEL SELL INDUSTRY CAPITAL GOODS CMP (as on 12 Aug 2014) Rs 224 Target Price Rs 188 Nifty 7,727 Sensex 25,881 KEY STOCK DATA Bloomberg/Reuters BHEL IN/BHEL.BO No. of Shares

More information

Central Depository Services

Central Depository Services INDUSTRY EXCHANGES CMP (as on 23 Apr 2018) Rs 296 Target Price Rs 415 Nifty 10,585 Sensex 34,451 KEY STOCK DATA Bloomberg CDSL IN No. of Shares (mn) 105 MCap (Rs bn) / ($ mn) 31/465 6m avg traded value

More information

Central Depository Services

Central Depository Services INDUSTRY EXCHANGES CMP (as on 30 Jul 2018) Rs 267 Target Price Rs 370 Nifty 11,320 Sensex 37,494 KEY STOCK DATA Bloomberg CDSL IN No. of Shares (mn) 105 MCap (Rs bn) / ($ mn) 28/406 6m avg traded value

More information

Ahluwalia Contracts. Cautious optimism BUY RESULTS REVIEW 4QFY17 31 MAY Highlights of the quarter

Ahluwalia Contracts. Cautious optimism BUY RESULTS REVIEW 4QFY17 31 MAY Highlights of the quarter RESULTS REVIEW 4QFY17 31 MAY 2017 Ahluwalia Contracts BUY INDUSTRY INFRASTRUCTURE CMP (as on 31 May 2017) Rs 350 Target Price Rs 393 Nifty 9,621 Sensex 31,146 KEY STOCK DATA Bloomberg AHLU IN No. of Shares

More information

Discounting $45/bbl of realisation

Discounting $45/bbl of realisation INDUSTRY OIL & GAS CMP (as on 13 Aug 2018) Rs 211 Target Price Rs 314 Nifty 11,356 Sensex 37,645 KEY STOCK DATA Bloomberg OINL IN No. of Shares (mn) 1,135 MCap (Rs bn) / (D mn) 241/3,450 6m avg traded

More information

Marico Kaya BUY RESULTS REVIEW 4QFY15 29 APR 2015

Marico Kaya BUY RESULTS REVIEW 4QFY15 29 APR 2015 RESULTS REVIEW 4QFY15 29 APR 2015 Marico Kaya INDUSTRY FMCG CMP (as on 28 Apr 2015) Rs 1,635 Target Price Rs 1,823 Nifty 8,240 Sensex 27,226 KEY STOCK DATA Bloomberg MAKA IN No. of Shares (mn) 13 MCap

More information

Margin boost through non-core book

Margin boost through non-core book INDUSTRY NBFCs CMP (as on 26 Apr 2017) Rs 676 Target Price Rs 600 Nifty 9,352 Sensex 30,133 KEY STOCK DATA Bloomberg LICHF IN No. of Shares (mn) 505 MCap (Rs bn) / ($ mn) 341/5,319 6m avg traded value

More information

NRB Bearings. Strong Show BUY RESULTS REVIEW 4QFY18 23 MAY Highlights of the quarter

NRB Bearings. Strong Show BUY RESULTS REVIEW 4QFY18 23 MAY Highlights of the quarter INDUSTRY AUTOS CMP(as on 23 May 2018) Rs 158 Target Price Rs 217 Nifty 10,430 Sensex 34,345 KEY STOCK DATA Bloomberg NRBBR IN No. of Shares (mn) 97 MCap (Rs bn) / ($ mn) 15/224 6m avg traded value (Rs

More information

Central Depository Services

Central Depository Services INDUSTRY EXCHANGES CMP (as on 29 Oct 2018) Rs 240 Target Price Rs 380 Nifty 10,251 Sensex 34,067 KEY STOCK DATA Bloomberg CDSL IN No. of Shares (mn) 105 MCap (Rs bn) / ($ mn) 25/341 6m avg traded value

More information

PI Industries BUY RESULTS REVIEW 1QFY19 07 AUG Highlights of the quarter

PI Industries BUY RESULTS REVIEW 1QFY19 07 AUG Highlights of the quarter RESULTS REVIEW 1QFY19 07 AUG 2018 PI Industries INDUSTRY AGROCHEMICAL CMP (as on 07 Aug 2018) Rs 766 Target Price Rs 900 Nifty 11,389 Sensex 37,666 KEY STOCK DATA Bloomberg PI IN No. of Shares (mn) 138

More information

Construction. 4QFY18E Results Preview 14 APR Parikshit D Kandpal

Construction. 4QFY18E Results Preview 14 APR Parikshit D Kandpal Construction 4QFY18E Results Preview 14 APR 2018 Parikshit D Kandpal parikshit.kandpal@hdfcsec.com +91-22-6171 7317 Kunal Bhandari kunal.bhandari@hdfcsec.com +91-22-6639 3035 4QFY15 1QFY16 2QFY16 3QFY16

More information

Sun Pharma BUY RESULTS REVIEW 1QFY19 16 AUG 2018

Sun Pharma BUY RESULTS REVIEW 1QFY19 16 AUG 2018 INDUSTRY PHARMA CMP (as on 14 Aug 2018) Rs 602 Target Price Rs 670 Nifty 11,435 Sensex 37,852 KEY STOCK DATA Bloomberg SUNP IN No. of Shares (mn) 2,399 MCap (Rs bn) / ($ mn) 1,444/20,662 6m avg traded

More information

Mahanagar Gas BUY RESULTS REVIEW 1QFY19 01 AUG Highlights of the quarter. CMP (as on 1 Aug 2018) Rs 947 Target Price Rs 1,292

Mahanagar Gas BUY RESULTS REVIEW 1QFY19 01 AUG Highlights of the quarter. CMP (as on 1 Aug 2018) Rs 947 Target Price Rs 1,292 INDUSTRY OIL & GAS CMP (as on 1 Aug 2018) Rs 947 Target Price Rs 1,292 Nifty 11,346 Sensex 37,522 KEY STOCK DATA Bloomberg MAHGL IN No. of Shares (mn) 99 MCap (Rs bn) / ($ mn) 94/1,367 6m avg traded value

More information

Hindustan Unilever BUY RESULTS REVIEW 4QFY17 18 MAY 2017

Hindustan Unilever BUY RESULTS REVIEW 4QFY17 18 MAY 2017 INDUSTRY FMCG CMP (as on 17 May 17) Rs 1,009 Target Price Rs 1,140 Nifty 9,526 Sensex 30,659 KEY STOCK DATA Bloomberg HUVR IN No. of Shares (mn) 2,164 MCap (Rs bn)/(us$ mn) 2,185/34,079 6m avg traded value

More information

Torrent Pharma BUY RESULTS REVIEW 1QFY18 01 AUG 2017

Torrent Pharma BUY RESULTS REVIEW 1QFY18 01 AUG 2017 INDUSTRY PHARMA CMP (as on 31 Jul 2017) Rs 1,317 Target Price Rs 1,450 Nifty 10,077 Sensex 32,515 KEY STOCK DATA Bloomberg TRP IN No. of Shares (mn) 169 MCap (Rs bn) / ($ mn) 223/3,472 6m avg traded value

More information

Alkem Labs BUY RESULTS REVIEW 1QFY19 11 AUG story remains on-track. Maintain BUY with a revised TP of Rs 2,410 (24x FY20E EPS).

Alkem Labs BUY RESULTS REVIEW 1QFY19 11 AUG story remains on-track. Maintain BUY with a revised TP of Rs 2,410 (24x FY20E EPS). INDUSTRY PHARMA CMP (as on 10 Aug 2018) Rs 2,060 Target Price Rs 2,410 Nifty 11,430 Sensex 37,869 KEY STOCK DATA Bloomberg ALKEM IN No. of Shares (mn) 120 MCap (Rs bn) / ($ mn) 246/3,576 6m avg traded

More information

Music Broadcast. In-line but muted BUY RESULTS REVIEW 2QFY19 26 OCT Key highlights. CMP (as on 26 Oct 2018) Rs 328 Target Price Rs 387

Music Broadcast. In-line but muted BUY RESULTS REVIEW 2QFY19 26 OCT Key highlights. CMP (as on 26 Oct 2018) Rs 328 Target Price Rs 387 RESULTS REVIEW 2QFY19 26 OCT 2018 Music Broadcast INDUSTRY MEDIA CMP (as on 26 Oct 2018) Rs 328 Target Price Rs 387 Nifty 10,030 Sensex 33,349 KEY STOCK DATA Bloomberg RADIOCITY IN No. of Shares (mn) 57

More information

Ambuja Cement. Realisations-driven beat SELL RESULTS REVIEW 2QCY17 25 JUL Highlights of the quarter

Ambuja Cement. Realisations-driven beat SELL RESULTS REVIEW 2QCY17 25 JUL Highlights of the quarter INDUSTRY CEMENT CMP (as on 24 July 2017) Rs 268 Target Price Rs 220 Nifty 9,966 Sensex 32,246 KEY STOCK DATA Bloomberg/Reuters ACEM IN No. of Shares (mn) 1,986 MCap (Rs bn) / ($ mn) 531/8,273 6m avg traded

More information

Strong volumes, offset by costs

Strong volumes, offset by costs RESULTS REVIEW 3QCY17 25 OCT 2017 Ambuja Cement SELL INDUSTRY CEMENT CMP (as on 24 Oct 2017) Rs 282 Target Price Rs 220 Nifty 10,208 Sensex 32,607 KEY STOCK DATA Bloomberg/Reuters ACEM IN No. of Shares

More information

Alkem Labs BUY RESULTS REVIEW 3QFY19 09 FEB CMP (as on 08 Feb 2019) Rs 1,904 Target Price Rs 2,340. Highlights of the quarter

Alkem Labs BUY RESULTS REVIEW 3QFY19 09 FEB CMP (as on 08 Feb 2019) Rs 1,904 Target Price Rs 2,340. Highlights of the quarter INDUSTRY PHARMA CMP (as on 08 Feb 2019) Rs 1,904 Target Price Rs 2,340 Nifty 10,944 Sensex 36,546 KEY STOCK DATA Bloomberg ALKEM IN No. of Shares (mn) 120 MCap (Rs bn) / ($ mn) 228/3,192 6m avg traded

More information

Vinati Organics BUY RESULTS REVIEW 2QFY19 29 OCT INDUSTRY CHEMICALS CMP (as on 29 Oct 2018) Rs 1,408 Target Price Rs 1,700

Vinati Organics BUY RESULTS REVIEW 2QFY19 29 OCT INDUSTRY CHEMICALS CMP (as on 29 Oct 2018) Rs 1,408 Target Price Rs 1,700 INDUSTRY CHEMICALS CMP (as on 29 Oct 2018) Rs 1,408 Target Price Rs 1,700 Nifty 10,251 Sensex 34,067 KEY STOCK DATA Bloomberg VO IN No. of Shares (mn) 51 MCap (Rs bn) / ($ mn) 72/986 6m avg traded value

More information

Geared for version 3.0

Geared for version 3.0 INDUSTRY APPLIANCES CMP (as on 22 May 18) Rs 1,460 Target Price Rs 1,983 Nifty 10,537 Sensex 34,651 KEY STOCK DATA Bloomberg SYML IN No. of Shares (mn) 70 MCap (Rsbn)/(US$ mn) 102/1,501 6m avg traded value

More information

Hindustan Petroleum Corporation

Hindustan Petroleum Corporation INDUSTRY OIL & GAS CMP (as on 08 Aug 2018) Rs 282 Target Price Rs 463 Nifty 11,450 Sensex 37,888 KEY STOCK DATA Bloomberg HPCL IN No. of Shares (mn) 1,524 MCap (Rs bn) / ($ mn) 431/6,274 6m avg traded

More information

Carborundum Universal

Carborundum Universal INDUSTRY CAPITAL GOODS CMP (as on 10 May 2017) Rs 296 Target Price Rs 340 Nifty 9,407 Sensex 30,248 KEY STOCK DATA Bloomberg /Reuters CU IN No. of Shares (mn) 189 MCap (Rs bn) / ($ mn) 56 / 863 6m avg

More information

Maruti Suzuki. A Trough Quarter BUY RESULTS REVIEW 3QFY19 25 JAN CMP(as on 25 Jan 2019) Rs 6,516 Target Price Rs 7,400

Maruti Suzuki. A Trough Quarter BUY RESULTS REVIEW 3QFY19 25 JAN CMP(as on 25 Jan 2019) Rs 6,516 Target Price Rs 7,400 INDUSTRY AUTOS CMP(as on 25 Jan 2019) Rs 6,516 Target Price Rs 7,400 Nifty 10,781 Sensex 36,026 KEY STOCK DATA Bloomberg MSIL IN No. of Shares (mn) 302 MCap (Rs bn) / ($ mn) 1,968 / 27,632 6m avg traded

More information

Hindustan Petroleum Corporation

Hindustan Petroleum Corporation RESULTS REVIEW 4QFY17 03 JUN 2017 Hindustan Petroleum Corporation INDUSTRY OIL & GAS CMP (as on 2 Jun 2017) Rs 537 Target Price Rs 550 Nifty 9,654 Sensex 31,273 KEY STOCK DATA Bloomberg HPCL IN No. of

More information

Real Estate. 4QFY17E Results Preview. 13 Apr Parikshit D Kandpal

Real Estate. 4QFY17E Results Preview. 13 Apr Parikshit D Kandpal Real Estate Results Preview 13 Apr 2017 Parikshit D Kandpal parikshitd.kandpal@hdfcsec.com +91-22-6171-7317 2QFY14 3QFY14 FY14 1QFY15 2QFY15 3QFY15 FY15 1QFY16 2QFY16 3QFY16 FY16 1QFY17 2QFY17 3QFY17 2QFY14

More information

Jubilant Life Sciences

Jubilant Life Sciences INDUSTRY PHARMA CMP (as on 23 Oct 2018) Rs 651 Target Price Rs 980 Nifty 10,245 Sensex 34,134 KEY STOCK DATA Bloomberg JUBILANT IN No. of Shares (mn) 159 MCap (Rs bn) / ($ mn) 104/1,412 6m avg traded value

More information

Dishman Carbogen Amcis

Dishman Carbogen Amcis INDUSTRY PHARMA CMP (as on 24 Jan 2019) Rs 222 Target Price Rs 380 Nifty 10,850 Sensex 36,195 KEY STOCK DATA Bloomberg DCAL IN No. of Shares (mn) 161 MCap (Rs bn) / ($ mn) 36/502 6m avg traded value (Rs

More information

Kalpataru Power Transmission

Kalpataru Power Transmission INDUSTRY CAPITAL GOODS CMP (as on 19 May 2017) Rs 352 Target Price Rs 403 Nifty 9,428 Sensex 30,465 KEY STOCK DATA Bloomberg /Reuters KPP IN No. of Shares (mn) 153 MCap (Rs bn) / ($ mn) 54/836 6m avg traded

More information

Reliance Industries. Timing is everything BUY COMPANY UPDATE 1 OCT 2014

Reliance Industries. Timing is everything BUY COMPANY UPDATE 1 OCT 2014 INDUSTRY OIL & GAS Timing is everything COMPANY UPDATE 1 OCT 2014 Reliance Industries BUY CMP (as on 30 Sep 2014) Rs 945 Target Price Rs 1,100 Nifty 7,965 Sensex 26,631 KEY STOCK DATA Bloomberg/Reuters

More information

Exide Industries BUY RESULTS REVIEW 4QFY18 08 MAY Highlights of the quarter. CMP (as on 08 May 2018) Rs 268 Target Price Rs 298

Exide Industries BUY RESULTS REVIEW 4QFY18 08 MAY Highlights of the quarter. CMP (as on 08 May 2018) Rs 268 Target Price Rs 298 INDUSTRY AUTOS CMP (as on 08 May 2018) Rs 268 Target Price Rs 298 Nifty 10,718 Sensex 35,216 KEY STOCK DATA Bloomberg EXID IN No. of Shares (mn) 850 MCap (Rs bn) / ($ mn) 227/3,390 6m avg traded value

More information

Bharti Infratel BUY RESULT REVIEW 3QFY19 25 JAN 2019

Bharti Infratel BUY RESULT REVIEW 3QFY19 25 JAN 2019 RESULT REVIEW 3QFY19 25 JAN 2019 Bharti Infratel INDUSTRY TELECOM CMP (as on 24 Jan 2019) Rs 263 Target Price Rs 344 Nifty 10,850 Sensex 36,195 KEY STOCK DATA Bloomberg BHIN IN No. of Shares (mn) 1,850

More information

Crompton Greaves Consumer Electricals

Crompton Greaves Consumer Electricals INDUSTRY APPLIANCES CMP (as on 26 Oct 2018) Rs 195 Target Price Rs 280 Nifty 10,030 Sensex 33,349 KEY STOCK DATA Bloomberg CROMPTON IN No. of Shares (mn) 627 MCap (Rsbn)/(US$ mn) 123/1,670 6m avg traded

More information

Radico Khaitan BUY RESULTS REVIEW 3QFY19 24 JAN 2019

Radico Khaitan BUY RESULTS REVIEW 3QFY19 24 JAN 2019 RESULTS REVIEW 24 JAN 2019 Radico Khaitan INDUSTRY ALCO BEV. CMP (as on 24 Jan 2019) Rs 428 Target Price Rs 592 Nifty 10,850 Sensex 36,195 KEY STOCK DATA Bloomberg RDCK IN No. of Shares (mn) 133 MCap (Rs

More information

Tata Steel. JV comes to fruition BUY COMPANY UPDATE 21 SEP Other key highlights. CMP (as on 20 Sep 17) Rs 688 Target Price Rs 818

Tata Steel. JV comes to fruition BUY COMPANY UPDATE 21 SEP Other key highlights. CMP (as on 20 Sep 17) Rs 688 Target Price Rs 818 INDUSTRY METALS CMP (as on 20 Sep 17) Rs 688 Target Price Rs 818 Nifty 10,141 Sensex 32,401 KEY STOCK DATA Bloomberg TATA IN No. of Shares (mn) 971 MCap (Rsbn) / ($ mn) 668/10,387 6m avg traded value (Rs

More information

Oil & Gas. 4QFY17E Results Preview. 13 Apr Deepak Kolhe

Oil & Gas. 4QFY17E Results Preview. 13 Apr Deepak Kolhe Oil & Gas Results Preview 13 Apr 2017 Satish Mishra satish.mishra@hdfcsec.com +91-22-6171-7334 Deepak Kolhe deepak.kolhe@hdfcsec.com +91-22-6171-7316 1QFY15 2QFY15 3QFY15 FY15 1QFY16 2QFY16 3QFY16 FY16

More information

J. Kumar Infraprojects

J. Kumar Infraprojects RESULTS REVIEW 2QFY19 14 NOV 2018 J. Kumar Infraprojects BUY INDUSTRY INFRASTRUCTURE CMP (as on 14 Nov 2018) Rs 150 Target Price Rs 284 Nifty 10,576 Sensex 35,142 KEY STOCK DATA Bloomberg JKIL IN No. of

More information

Pre-sales pickup key trigger

Pre-sales pickup key trigger RESULTS REVIEW 1QFY19 18 AUG 2018 Brigade Enterprises INDUSTRY REAL ESTATE CMP (as on 17 Aug 2018) Rs 192 Target Price Rs 299 Nifty 11,471 Sensex 37,948 KEY STOCK DATA Bloomberg BRGD IN No. of Shares (mn)

More information

Bajaj Auto BUY RESULTS REVIEW 1QFY18 21 JUL Highlights of the quarter

Bajaj Auto BUY RESULTS REVIEW 1QFY18 21 JUL Highlights of the quarter INDUSTRY AUTOS CMP (as on 20 July 2017) Rs 2,819 Target Price Rs 3,296 Nifty 9,873 Sensex 31,904 KEY STOCK DATA Bloomberg BJAUT IN No. of Shares (mn) 289 MCap (Rs bn) / ($ mn) 816 / 12,658 6m avg traded

More information

Dilip Buildcon. Strong comeback BUY RESULT REVIEW 1QFY19 16 AUG Highlights of the quarter. CMP (as on 16 Aug 2018) Rs 847 Target Price Rs 1,434

Dilip Buildcon. Strong comeback BUY RESULT REVIEW 1QFY19 16 AUG Highlights of the quarter. CMP (as on 16 Aug 2018) Rs 847 Target Price Rs 1,434 INDUSTRY INFRASTRUCTURE CMP (as on 16 Aug 2018) Rs 847 Target Price Rs 1,434 Nifty 11,385 Sensex 37,664 KEY STOCK DATA Bloomberg DBL IN No. of Shares (mn) 137 MCap (Rs bn) / ($ mn) 116/1,656 5m avg traded

More information

Dr. Reddy s Labs. Misery continues SELL RESULTS REVIEW 1QFY18 28 JUL 2017

Dr. Reddy s Labs. Misery continues SELL RESULTS REVIEW 1QFY18 28 JUL 2017 INDUSTRY PHARMA CMP (as on 27 Jul 2017) Rs 2,621 Target Price Rs 2,275 Nifty 10,021 Sensex 32,383 KEY STOCK DATA Bloomberg DRRD IN No. of Shares (mn) 166 MCap (Rs bn) / ($ mn) 435/6,778 6m avg traded value

More information

Sonata Software. On growth path BUY RESULTS REVIEW 1QFY18 16 AUG Highlights of the quarter

Sonata Software. On growth path BUY RESULTS REVIEW 1QFY18 16 AUG Highlights of the quarter INDUSTRY IT CMP (as on 16 Aug 217) Rs 16 Target Price Rs 2 Nifty 9,897 Sensex 31,771 KEY STOCK DATA Bloomberg/Reuters SSOF IN No. of Shares (mn) 15 MCap (Rs bn) / ($ mn) 17/262 6m avg traded value (Rs

More information

PSP Projects. Marginal miss BUY RESULTS REVIEW 1QFY19 10 AUG 2018

PSP Projects. Marginal miss BUY RESULTS REVIEW 1QFY19 10 AUG 2018 RESULTS REVIEW 1QFY19 10 AUG 2018 PSP Projects INDUSTRY INFRASTRUCTURE CMP (as on 9 Aug 2018) Rs 482 Target Price Rs 639 Nifty 11,471 Sensex 38,024 KEY STOCK DATA Bloomberg PSPPL IN No. of Shares (mn)

More information

Brigade Enterprises. Stable performance BUY RESULTS REVIEW 2QFY19 14 NOV 2018

Brigade Enterprises. Stable performance BUY RESULTS REVIEW 2QFY19 14 NOV 2018 INDUSTRY REAL ESTATE CMP (as on 13 Nov 2018) Rs 177 Target Price Rs 306 Nifty 10,583 Sensex 35,144 KEY STOCK DATA Bloomberg BRGD IN No. of Shares (mn) 136 MCap (Rs bn) / ($ mn) 24/333 6m avg traded value

More information

Chemicals and Fertilisers

Chemicals and Fertilisers Chemicals and Fertilisers 4QFY17E Results Preview 13 APR 2017 Satish Mishra satish.mishra@hdfcsec.com +91-22-6171-7334 Deepak Kolhe deepak.kolhe@hdfcsec.com +91-22-6171-7316 4QFY17E: Muted growth The sowing

More information

NIIT Technologies. NEUTRAL Higher capex weighing on FCF RESULTS REVIEW 2QFY15 16 OCT 2014

NIIT Technologies. NEUTRAL Higher capex weighing on FCF RESULTS REVIEW 2QFY15 16 OCT 2014 RESULTS REVIEW 2QFY15 16 OCT 2014 NIIT Technologies NEUTRAL INDUSTRY IT SERVICES Higher capex weighing on FCF CMP (as on 14 Oct 2014) Rs 394 Target Price Rs 406 Nifty 7,864 Sensex 26,349 KEY STOCK DATA

More information

Weak numbers in peak quarter

Weak numbers in peak quarter INDUSTRY CEMENT CMP (as on 21 April 17) Rs 1,495 Target Price Rs 1,300 Nifty 9,119 Sensex 29,365 KEY STOCK DATA Bloomberg/Reuters ACC IN No. of Shares (mn) 188 MCap (Rs bn) / ($ mn) 281/4,346 6m avg traded

More information

Subros BUY RESULTS REVIEW 2QFY19 30 OCT CMP (as on 29 Oct 2018) Rs 268 TP Rs 435. Key highlights

Subros BUY RESULTS REVIEW 2QFY19 30 OCT CMP (as on 29 Oct 2018) Rs 268 TP Rs 435. Key highlights INDUSTRY AUTOS CMP (as on 29 Oct 2018) Rs 268 TP Rs 435 Nifty 10,251 Sensex 34,067 KEY STOCK DATA Bloomberg SUBR IN No. of Shares (mn) 60 MCap (Rsbn) / ($ mn) 16/219 6m avg traded value (Rsmn) 20 STOCK

More information

ICICI Prudential Life Insurance

ICICI Prudential Life Insurance Margins were positive surprise; APE growth was slow January 21, 2018 Vidhi Shah vidhishah@plindia.com / +91 22 66322258 R Sreesankar rsreesankar@plindia.com / +91 22 66322214 Pritesh Bumb priteshbumb@plindia.com

More information

Hero MotoCorp BUY RESULTS REVIEW 2QFY19 16 OCT CMP (as on 16 Oct 2018) Rs 2,898 Target Price Rs 3,602. Highlights of the quarter

Hero MotoCorp BUY RESULTS REVIEW 2QFY19 16 OCT CMP (as on 16 Oct 2018) Rs 2,898 Target Price Rs 3,602. Highlights of the quarter INDUSTRY AUTOS CMP (as on 16 Oct 2018) Rs 2,898 Target Price Rs 3,602 Nifty 10,585 Sensex 35,162 KEY STOCK DATA Bloomberg HMCL IN No. of Shares (mn) 200 MCap (Rs bn) / ($ mn) 578 / 7,855 6m avg traded

More information

JBM Auto. Ready to take off BUY RESULTS REVIEW 1QFY19 07 AUG Key highlights

JBM Auto. Ready to take off BUY RESULTS REVIEW 1QFY19 07 AUG Key highlights INDUSTRY AUTOS CMP (as on 06 Aug 2018) Rs 383 TP Rs 560 Nifty 11,387 Sensex 37,692 KEY STOCK DATA Bloomberg JBMA IN No. of Shares (mn) 41 MCap (Rs bn) / ($ mn) 16/227 6m avg traded value (Rs mn) 29 STOCK

More information

Multi Commodity Exchange

Multi Commodity Exchange INDUSTRY EXCHANGES CMP (as on 4 May 2017) Rs 1,155 Target Price Rs 1,558 Nifty 9,360 Sensex 30,126 KEY STOCK DATA Bloomberg MCX IN No. of Shares (mn) 51 MCap (Rs bn) / ($ mn) 59/917 6m avg traded value

More information

Mphasis. Growth drivers intact BUY RESULTS REVIEW 3QFY19 25 JAN 2019

Mphasis. Growth drivers intact BUY RESULTS REVIEW 3QFY19 25 JAN 2019 INDUSTRY IT CMP (as on 25 Jan 2019) Rs 921 Target Price Rs 1,390 Nifty 10,781 Sensex 36,026 KEY STOCK DATA Bloomberg MPHL IN No. of Shares (mn) 193 MCap (Rs bn) / ($ mn) 178/2,502 6m avg traded value (Rs

More information

SBI Life Insurance Company (SBILIFE IN ) Rating: BUY CMP: Rs673 TP: Rs840

SBI Life Insurance Company (SBILIFE IN ) Rating: BUY CMP: Rs673 TP: Rs840 (SBILIFE IN ) Rating: BUY CMP: Rs673 TP: Rs840 July 20, 2018 Q1FY19 Result Update Continued improvement in biz yielding results Quick Pointers Company focuses to grow in protection (both segments) and

More information

Bharat Petroleum Corporation

Bharat Petroleum Corporation INDUSTRY OIL & GAS CMP (as on 30 May 2017) Rs 738 Target Price Rs 720 Nifty 9,625 Sensex 31,159 KEY STOCK DATA Bloomberg BPCL IN No. of Shares (mn) 1,446 MCap (Rs bn) / ($ mn) 1,067/16,510 6m avg traded

More information

Construction & Infra. 1QFY19E Results Preview 10 JUL Parikshit D Kandpal

Construction & Infra. 1QFY19E Results Preview 10 JUL Parikshit D Kandpal Construction & Infra 1QFY19E Results Preview 10 JUL 2018 Parikshit D Kandpal parikshitd.kandpal@hdfcsec.com +91-22-6171 7317 Kunal Bhandari kunal.bhandari@hdfcsec.com +91-22-6639 3035 1QFY16 2QFY16 3QFY16

More information

HDFC Standard Life Insurance

HDFC Standard Life Insurance Decent performance on all fronts January 21, 2018 Vidhi Shah vidhishah@plindia.com / +91 22 66322258 R Sreesankar rsreesankar@plindia.com / +91 22 66322214 Pritesh Bumb priteshbumb@plindia.com / +91 22

More information

Overview of Life insurance industry. Date :

Overview of Life insurance industry. Date : Overview of Life insurance industry Date : 15.11.2017 INDEX 1. Meaning 2. Glossary 3. Type of Life insurance 4. How they earn 5. Industry evolution 6. World Data 7. Domestic Data 8. Risk 10. Data about

More information

Navin Fluorine International

Navin Fluorine International INDUSTRY CHEMICALS CMP (as on 02 May 17) Rs 3,002 Target Price Rs 3,300 Nifty 9,314 Sensex 29,921 KEY STOCK DATA Bloomberg NFIL IN No. of Shares (mn) 10 MCap (Rs bn) / ($ mn) 29/458 6m avg traded value

More information

Cyient. Good show, priced in NEUTRAL RESULTS REVIEW 4QFY17 21 APRIL Highlights of the quarter

Cyient. Good show, priced in NEUTRAL RESULTS REVIEW 4QFY17 21 APRIL Highlights of the quarter INDUSTRY IT CMP (as on 20 Apr 2017) Rs 503 Target Price Rs 540 Nifty 9,136 Sensex 29,422 KEY STOCK DATA Bloomberg CYL IN No. of Shares (mn) 113 MCap (Rs bn) / ($ mn) 57/876 6m avg traded value (Rs mn)

More information

Ambuja Cement. Weak numbers SELL RESULTS REVIEW 1QCY17 01 MAY 2017

Ambuja Cement. Weak numbers SELL RESULTS REVIEW 1QCY17 01 MAY 2017 INDUSTRY CEMENT CMP (as on 28 Apr 2017) Rs 246 Target Price Rs 200 Nifty 9,304 Sensex 29,918 KEY STOCK DATA Bloomberg/Reuters ACEM IN No. of Shares (mn) 1,986 MCap (Rsbn) / ($ mn) 487/7,586 6m avg traded

More information

HDFC Standard Life Insurance Company (HDFCLIFE IN ) Rating: BUY CMP: Rs359 TP: Rs500

HDFC Standard Life Insurance Company (HDFCLIFE IN ) Rating: BUY CMP: Rs359 TP: Rs500 HDFC Standard Life Insurance Company (HDFCLIFE IN ) Rating: BUY CMP: Rs359 TP: Rs500 October 24, 2018 Q2FY19 Result Update Margins on rise mainly led by protection biz Quick Pointers Protection share has

More information

Emami NEUTRAL RESULTS REVIEW 4QFY15 14 MAY 2015

Emami NEUTRAL RESULTS REVIEW 4QFY15 14 MAY 2015 RESULTS REVIEW 4QFY15 14 MAY 2015 Emami NEUTRAL INDUSTRY FMCG CMP (as on 13 May 2015) Rs 937 Target Price Rs 910 Nifty 8,235 Sensex 27,251 KEY STOCK DATA Bloomberg/Reuters HMN IN/EMAM.BO No. of Shares

More information

Coromandel International

Coromandel International INDUSTRY FERTILISER CMP (as on 2 May 2017) Rs 360 Target Price Rs 385 Nifty 9,314 Sensex 29,921 KEY STOCK DATA Bloomberg CRIN IN No. of Shares (mn) 292 MCap (Rs bn) / ($ mn) 105/1,634 6m avg traded value

More information

Karur Vysya Bank BUY RESULTS REVIEW 1QFY19 26 JUL 2018

Karur Vysya Bank BUY RESULTS REVIEW 1QFY19 26 JUL 2018 INDUSTRY BANKS CMP (as on 26 Jul 2018) Rs 98 Target Price Rs 148 Nifty 11,167 Sensex 36,985 KEY STOCK DATA Bloomberg KVB IN No. of Shares (mn) 726 MCap (Rs bn) / ($ mn) 72/1,041 6m avg traded value (Rs

More information

Suprajit Engineering. Synergies to accrue BUY COMPANY UPDATE 16 SEP 2016

Suprajit Engineering. Synergies to accrue BUY COMPANY UPDATE 16 SEP 2016 COMPANY UPDATE 16 SEP 016 Suprajit Engineering INDUSTRY AUTOS CMP(as on 15 Sept 016) Rs 199 Target Price Rs 4 Nifty 8,743 Sensex 8,413 KEY STOCK DATA Bloomberg SEL IN No. of Shares (mn) 131 MCap (Rsbn)

More information

Bajaj Auto NEUTRAL RESULTS REVIEW 2QFY16 23 OCT Key highlights. CMP (as on 23 Oct 2015) Rs 2,514 Target Price Rs 2,720

Bajaj Auto NEUTRAL RESULTS REVIEW 2QFY16 23 OCT Key highlights. CMP (as on 23 Oct 2015) Rs 2,514 Target Price Rs 2,720 INDUSTRY AUTOS CMP (as on 23 Oct 2015) Rs 2,514 Target Price Rs 2,720 Nifty 8,295 Sensex 27,471 KEY STOCK DATA Bloomberg/Reuters BJAUT IN/BAJA.BO No. of Shares (mn) 289 MCap (Rs bn) / ($ mn) 728 / 11,216

More information

Thangamayil BUY RESULTS REVIEW 2QFY19 15 NOV 2018

Thangamayil BUY RESULTS REVIEW 2QFY19 15 NOV 2018 INDUSTRY JEWELLERY RETAIL FMCG CMP (as on 27 14 Nov Jul 2017) 2018) Rs 289 347 Target Price Rs 353 625 Nifty 10,021 10,576 Sensex 32,383 35,142 KEY STOCK DATA Bloomberg ITC TJL IN No. of Shares (mn) 12,161

More information

ICICI Bank BUY RESULTS REVIEW 4QFY17 04 MAY Highlights of the quarter. CMP (as on 3 May 2017) Rs 273 Target Price Rs 345

ICICI Bank BUY RESULTS REVIEW 4QFY17 04 MAY Highlights of the quarter. CMP (as on 3 May 2017) Rs 273 Target Price Rs 345 INDUSTRY BANKS CMP (as on 3 May 2017) Rs 273 Target Price Rs 345 Nifty 9,312 Sensex 29,895 KEY STOCK DATA Bloomberg ICICIBC IN No. of Shares (mn) 5,825 MCap (Rs bn) / ($ mn) 1,587/24,768 6m avg traded

More information

Insecticides India BUY RESULTS REVIEW 4QFY17 30 MAY 2017

Insecticides India BUY RESULTS REVIEW 4QFY17 30 MAY 2017 INDUSTRY AGROCHEMICAL CMP (as on 29 May 2017) Rs 648 Target Price Rs 710 Nifty 9,605 Sensex 31,109 KEY STOCK DATA Bloomberg INST IN No. of Shares (mn) 21 MCap (Rs bn) / ($ mn) 13/208 6m avg traded value

More information

ITC BUY RESULTS REVIEW 1QFY19 27 JUL 2018

ITC BUY RESULTS REVIEW 1QFY19 27 JUL 2018 INDUSTRY FMCG CMP (as on 27 26 Jul 2018) 2017) Rs 287 289 Target Price Rs 353 367 Nifty 10,021 11,167 Sensex 32,383 36,985 KEY STOCK DATA Bloomberg ITC IN No. of Shares (mn) 12,161 12,218 MCap (Rs bn)/(us$

More information

1%+ RoA on the horizon

1%+ RoA on the horizon ANNUAL REPORT ANALYSIS 18 MAY 2017 DCB Bank INDUSTRY BANKS CMP (as on 17 May 2017) Rs 197 Target Price Rs 221 Nifty 9,526 Sensex 30,659 KEY STOCK DATA Bloomberg/Reuters DCBB IN No. of Shares (mn) 307 MCap

More information

V-Guard BUY RESULTS REVIEW 3QFY19 02 FEB 2019

V-Guard BUY RESULTS REVIEW 3QFY19 02 FEB 2019 INDUSTRY APPLIANCES CMP (as on 01 Feb 2019) Rs 199 Target Price Rs 238 Nifty 10,894 Sensex 36,469 KEY STOCK DATA Bloomberg VGRD IN No. of Shares (mn) 427 MCap (Rs bn)/(us$ mn) 85/1,193 6m avg traded value

More information

FIRSTSOURCE SOLUTIONS LTD.

FIRSTSOURCE SOLUTIONS LTD. Industry BPO/KPO CMP Rs. 38 Recommendation Buy on Dips Add on dips to Rs. 36-33 Target Rs. 47-55 Time Horizon 6 Quarters HDFC Scrip Code FIRSOL BSE Code 532809 NSE Code Bloomberg FSL FSOL CMP as on 2 Feb

More information

SBI Life Insurance. Source: Company Data; PL Research

SBI Life Insurance. Source: Company Data; PL Research Recent correction gives further reason to enter March 15, 2018 Vidhi Shah vidhishah@plindia.com / +91 22 66322258 R Sreesankar rsreesankar@plindia.com / +91 22 66322214 Pritesh Bumb priteshbumb@plindia.com

More information

SBI Life Insurance Company (SBILIFE IN ) Rating: BUY CMP: Rs620 TP: Rs779

SBI Life Insurance Company (SBILIFE IN ) Rating: BUY CMP: Rs620 TP: Rs779 (SBILIFE IN ) Rating: BUY CMP: Rs620 TP: Rs779 January 18, 2019 Q3FY19 Result Update Strong growth with steady metrics Quick Pointers Strong growth displayed in protection business with +4x growth YoY

More information

Growth + cash flows = BUY

Growth + cash flows = BUY INDUSTRY AUTOS CMP (as on 20 Apr 2018) Rs 328 TP Rs 384 Nifty 10,564 Sensex 34,465 KEY STOCK DATA Bloomberg SUBR IN No. of Shares (mn) 60 MCap (Rsbn) / ($ mn) 20/300 6m avg traded value (Rsmn) 50 STOCK

More information

Hexaware Technologies

Hexaware Technologies INDUSTRY IT CMP (as on 24 Apr 2017) Rs 220 Target Price Rs 215 Nifty 9,218 Sensex 29,656 KEY STOCK DATA Bloomberg/Reuters HEXW IN No. of Shares (mn) 302 MCap (Rs bn) / ($ mn) 67/1,033 6m avg traded value

More information

Cement, Metals & Mining

Cement, Metals & Mining Cement, Metals & Mining 4QFY17E Results Preview 13 Apr 2017 Ankur Kulshrestha, CFA ankur.kulshrestha@hdfcsec.com +91-22-6171 7346 Sarfaraz Singh sarfaraz.singh@hdfcsec.com +91-22-6171 7331 Mar-15 Apr-15

More information